OGDH: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== | {{Infobox enzyme | ||
OGDH is | | name = 2-oxoglutarate dehydrogenase | ||
| image = <!-- Image removed --> | |||
| width = | |||
| caption = | |||
| EC_number = 1.2.4.2 | |||
| CAS_number = 9028-91-7 | |||
| GO_code = 0004591 | |||
}} | |||
'''2-oxoglutarate dehydrogenase''' ('''OGDH''') is an important [[enzyme]] in the [[citric acid cycle]] (also known as the [[Krebs cycle]] or [[TCA cycle]]). It catalyzes the conversion of [[2-oxoglutarate]] (also known as [[alpha-ketoglutarate]]) into [[succinyl-CoA]] and [[carbon dioxide]]. This reaction is a key step in the metabolic pathway that generates [[adenosine triphosphate]] (ATP) through the oxidation of [[acetyl-CoA]]. | |||
== Function == | == Function == | ||
OGDH is a component of the [[2-oxoglutarate dehydrogenase complex]], which is a multi-enzyme complex that also includes [[dihydrolipoamide succinyltransferase]] and [[dihydrolipoamide dehydrogenase]]. This complex is responsible for the decarboxylation of 2-oxoglutarate, a critical step in the citric acid cycle. | |||
== Structure == | |||
The enzyme is a large, multi-subunit complex that requires several [[cofactors]] for its activity, including [[thiamine pyrophosphate]] (TPP), [[lipoic acid]], [[coenzyme A]] (CoA), [[FAD]], and [[NAD+]]. | |||
== Clinical significance == | == Clinical significance == | ||
Mutations in | Mutations or deficiencies in OGDH can lead to metabolic disorders and have been associated with [[neurological diseases]]. The enzyme's activity is crucial for maintaining normal cellular energy levels, and its dysfunction can result in [[mitochondrial diseases]]. | ||
[[ | == Regulation == | ||
OGDH activity is regulated by the availability of its substrates and cofactors, as well as by feedback inhibition from its products, such as [[NADH]] and [[succinyl-CoA]]. | |||
== See also == | == See also == | ||
* [[ | * [[Citric acid cycle]] | ||
* [[ | * [[Mitochondrial diseases]] | ||
* [[ | * [[Enzyme regulation]] | ||
== References == | == References == | ||
<references /> | <references/> | ||
== External links == | |||
* [https://www.wikimd.com/wiki/OGDH OGDH on WikiMD] | |||
{{Enzymes}} | |||
{{Citric acid cycle}} | |||
[[Category:Enzymes]] | [[Category:Enzymes]] | ||
[[Category: | [[Category:Citric acid cycle]] | ||
[[Category: | [[Category:EC 1.2.4]] | ||
[[Category:Mitochondrial proteins]] | |||
Latest revision as of 20:20, 30 December 2024
OGDH
2-oxoglutarate dehydrogenase (OGDH) is an important enzyme in the citric acid cycle (also known as the Krebs cycle or TCA cycle). It catalyzes the conversion of 2-oxoglutarate (also known as alpha-ketoglutarate) into succinyl-CoA and carbon dioxide. This reaction is a key step in the metabolic pathway that generates adenosine triphosphate (ATP) through the oxidation of acetyl-CoA.
Function[edit]
OGDH is a component of the 2-oxoglutarate dehydrogenase complex, which is a multi-enzyme complex that also includes dihydrolipoamide succinyltransferase and dihydrolipoamide dehydrogenase. This complex is responsible for the decarboxylation of 2-oxoglutarate, a critical step in the citric acid cycle.
Structure[edit]
The enzyme is a large, multi-subunit complex that requires several cofactors for its activity, including thiamine pyrophosphate (TPP), lipoic acid, coenzyme A (CoA), FAD, and NAD+.
Clinical significance[edit]
Mutations or deficiencies in OGDH can lead to metabolic disorders and have been associated with neurological diseases. The enzyme's activity is crucial for maintaining normal cellular energy levels, and its dysfunction can result in mitochondrial diseases.
Regulation[edit]
OGDH activity is regulated by the availability of its substrates and cofactors, as well as by feedback inhibition from its products, such as NADH and succinyl-CoA.
See also[edit]
References[edit]
<references/>
External links[edit]
| Enzymes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|